A reduction of SOCS1 by JAK inhibitors, which are efficacious drugs for the therapy of AD, was accompanied by restored maturation of the cells upon TLR2‐engagement confirming that SOCS1 contributes to the functional change of the LC. Here, TLR2 is linked to Alzheimer disease.